People who survive cancer in childhood have a higher risk of ill health as they grow older, according to new research published in The Lancet Regional Health – Europe.
Hodgkin lymphoma patients can be spared the serious side effects of chemotherapy thanks to high-tech scans that can predict the outcome of treatment.
A gene test may improve the way doctors treating women with early-stage breast cancer identify those who can safely avoid post-surgery chemotherapy.
Researchers have for the first time calculated by how much radiotherapy for breast cancer increases the risk of heart disease and the findings can now be used by doctors to help treat patients more appropriately.
Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology.
The chronic side-effects of radiotherapy for early breast cancer, as reported by women themselves, are not any worse when treatment is given in a lower overall dose in fewer but larger treatments according to a trial part funded by Cancer Research UK and published today in the Lancet Oncology.
An Experimental cancer therapy for prostate cancer may be able to treat men without surgery and offer fewer side effects according to the results of a UK study published in the British Journal of Cancer* today (Wednesday).
Hot flushes, night sweats and painful joints can be a blessing in disguise for breast cancer patients – according to a new report published online today in Lancet Oncology.
A common osteoporosis drug can shield women against the loss of bone mineral density – a side effect of the drug anastrozole which is taken to prevent breast cancer in the IBIS-2 study – according to new data presented today at the San Antonio Breast Cancer Symposium.